Our results showed that miR-27b-3p mimics significantly attenuated both protein and mRNA levels of NR5A2 and CREB1, whereas miR-509-5p inhibitors observably enhanced the protein and mRNA levels of the two genes in all the four breast cancer cells (Figure 4a–h). This evidence concerns the gene CREB1 and breast carcinoma.